PolyPeptide Group AG (SWX:PPGN)

PolyPeptide Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	68.28	95.71	37.53	136.3	17.21
Cash & Short-Term Investments	68.28	95.71	37.53	136.3	17.21
Cash Growth	-28.66%	155.03%	-72.47%	692.09%	-1.71%
Accounts Receivable	86.26	78.78	49.15	67.79	55.54
Other Receivables	21.2	17.21	13.27	8.14	9.6
Receivables	107.46	95.98	62.41	75.92	65.14
Inventory	146.35	128.51	145.07	113	94.27
Prepaid Expenses	5.99	5.09	5	4.75	2.53
Other Current Assets	0.14	1.32	1.56	1.63	0.72
Total Current Assets	328.22	326.6	251.57	331.61	179.86
Property, Plant & Equipment	388.99	324.11	297.29	235.44	169.81
Long-Term Investments	5.16	5.24	2.77	3.47	0.2
Other Intangible Assets	15.02	16.45	15.87	14.27	12.56
Long-Term Deferred Tax Assets	17.62	16.69	8.29	10.26	13.55
Long-Term Deferred Charges	1.56	-	-	-	-
Total Assets	756.58	689.09	575.78	595.04	375.98
Accounts Payable	73.26	60.91	45.93	28.48	28.36
Accrued Expenses	22.54	24.02	17.19	20.48	18.71
Current Portion of Long-Term Debt	31.91	42.48	1.1	1.15	3.5
Current Portion of Leases	5.07	4.45	3.57	3.06	1.98
Current Income Taxes Payable	0.36	0.23	0.07	4	8.28
Current Unearned Revenue	60.48	42.97	27.54	46.13	34.07
Other Current Liabilities	0.89	1.39	0.66	0.67	6.96
Total Current Liabilities	194.5	176.45	96.05	103.96	101.85
Long-Term Debt	48.93	58.98	9.41	10.3	35.9
Long-Term Leases	18.98	18.87	17.65	14.95	10.45
Long-Term Unearned Revenue	99.64	23.16	-	-	-
Long-Term Deferred Tax Liabilities	3.21	3.64	1.88	1.11	0.88
Other Long-Term Liabilities	1.94	1.65	2.48	4.57	10.11
Total Liabilities	399.33	307.86	154.11	173.87	198.32
Common Stock	0.3	0.3	0.3	0.3	33
Additional Paid-In Capital	203.13	203.13	203.13	212.8	2.34
Retained Earnings	140.48	165.14	214.15	196.03	147.94
Treasury Stock	-8.4	-10.39	-13.61	-1.19	-
Comprehensive Income & Other	21.73	23.05	17.71	13.23	-5.62
Shareholders' Equity	357.24	381.23	421.68	421.17	177.66
Total Liabilities & Equity	756.58	689.09	575.78	595.04	375.98
Total Debt	104.89	124.78	31.72	29.45	51.83
Net Cash (Debt)	-36.61	-29.08	5.8	106.85	-34.62
Net Cash Growth	-	-	-94.57%	-	-
Net Cash Per Share	-1.11	-0.88	0.18	3.33	-1.15
Filing Date Shares Outstanding	33	32.97	32.93	33.1	30
Total Common Shares Outstanding	33	32.97	32.93	33.1	30
Working Capital	133.72	150.15	155.52	227.65	78.01
Book Value Per Share	10.83	11.56	12.81	12.72	5.92
Tangible Book Value	342.23	364.77	405.81	406.91	165.1
Tangible Book Value Per Share	10.37	11.06	12.33	12.29	5.50
Land	147.37	129.94	124.02	87.67	94.66
Machinery	319.26	243.43	201.16	170.55	138.83
Construction In Progress	88.43	91.17	98.64	87.4	49.57

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.